BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9775145)

  • 1. [Effectiveness of thalidomide treatment during cutaneous sarcoidosis].
    Grasland A; Pouchot J; Chaumaizière D; Aitken G; Vinceneux P
    Rev Med Interne; 1998 Mar; 19(3):208-9. PubMed ID: 9775145
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thalidomide in the treatment of cutaneous and systemic sarcoidosis].
    Hoch O; Müller S; Büttner G; Mensing H
    Hautarzt; 2001 Oct; 52(10 Pt 2):962-5. PubMed ID: 11715394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report.
    Lee JB; Koblenzer PS
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):835-8. PubMed ID: 9810910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sarcoidosis: thalidomide treatment in ten patients].
    Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A
    Ann Dermatol Venereol; 2001 May; 128(5):611-3. PubMed ID: 11427794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide and its dermatologic uses.
    Moraes M; Russo G
    Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.
    Oliver SJ; Kikuchi T; Krueger JG; Kaplan G
    Clin Immunol; 2002 Mar; 102(3):225-36. PubMed ID: 11890709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cutaneous sarcoidosis with thalidomide.
    Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbé C; Morel P; Rybojad M
    J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comment on O. Hoch et al.: "Thalidomide in treatment of cutaneous and systemic sarcoidosis"].
    Ochsendorf F; Kaufmann R
    Hautarzt; 2002 Feb; 53(2):150; author reply 150-1. PubMed ID: 11963196
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous sarcoidosis successfully treated with low doses of thalidomide.
    Rousseau L; Beylot-Barry M; Doutre MS; Beylot C
    Arch Dermatol; 1998 Aug; 134(8):1045-6. PubMed ID: 9722748
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous sarcoidosis. Treatment with thalidomide].
    Barriere H
    Presse Med; 1983 Apr; 12(15):963. PubMed ID: 6221259
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.
    Carlesimo M; Giustini S; Rossi A; Bonaccorsi P; Calvieri S
    J Am Acad Dermatol; 1995 May; 32(5 Pt 2):866-9. PubMed ID: 7722046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis.
    Brechtel B; Haas N; Henz BM; Kolde G
    Br J Dermatol; 1996 Aug; 135(2):307-9. PubMed ID: 8881681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous sarcoidosis therapy updated.
    Badgwell C; Rosen T
    J Am Acad Dermatol; 2007 Jan; 56(1):69-83. PubMed ID: 17190623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
    Droitcourt C; Rybojad M; Porcher R; Juillard C; Cosnes A; Joly P; Lacour JP; D'Incan M; Dupin N; Sassolas B; Misery L; Chevrant-Breton J; Lebrun-Vignes B; Desseaux K; Valeyre D; Revuz J; Tazi A; Chosidow O; Dupuy A
    Chest; 2014 Oct; 146(4):1046-1054. PubMed ID: 24945194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
    Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
    Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.
    Baughman RP; Judson MA; Ingledue R; Craft NL; Lower EE
    Arch Dermatol; 2012 Feb; 148(2):262-4. PubMed ID: 22004880
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: single-center retrospective study of 9 patients.
    Sené T; Juillard C; Rybojad M; Cordoliani F; Lebbé C; Morel P; Tazi A; Guibal F
    J Am Acad Dermatol; 2012 Feb; 66(2):328-32. PubMed ID: 22243729
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thalidomide].
    Laffitte E; Revuz J
    Ann Dermatol Venereol; 2000; 127(6-7):603-13. PubMed ID: 10930858
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide for chronic sarcoidosis.
    Baughman RP; Judson MA; Teirstein AS; Moller DR; Lower EE
    Chest; 2002 Jul; 122(1):227-32. PubMed ID: 12114363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.